DEVELOPING HIGH RESOLUTION RFLPS FOR HUMAN GENETIC ANALYSIS
DEVELOPING HIGH RESOLUTION RFLPS FOR HUMAN GENETIC ANALYSIS
批准号:
3838461
负责人:
M DEAN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
CD4 molecule DNA chromosomes conformation family genetics genetic mapping genetic markers genetic polymorphism human genetic material tag method development nucleic acid hybridization nucleic acid repetitive sequence nucleic acid sequence polymerase chain reaction restriction fragment length polymorphism tumor necrosis factor alpha
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The genetic maps for most of the human chromosomes have been generated
using restriction fragment length polymorphisms (RFLPs). Of the 5,000
known RFLPs that have been described, there are only 1,500 polymorphisms
in coding genes. This represents a small fraction of the 50-100,000 genes
that are believed to be encoded in the entire genome. In order to
characterize polymorphisms in biologically important human genes, we have
employed both standard approaches, as well as new methods to identify
genetic markers. These methods include identification of RFLPs by DNA
hybridization, characterization of single-stranded conformation
polymorphisms (SSCPs) in non-coding portions of genes, and the use of
microsatel-lite loci in and near known genes. Polymorphisms have been
described in the tryptophan hydroxylase gene (TPH), the gamma 2 subunit of
the GABA receptor (GABARG2), a transcription factor gene that regulates
apolipoproteins, a tyrosine kinase gene (RLK), transketolase, a serotonin
receptor (HTR1A), and the vacuolar H+-ATPase gene. Many of these genetic
markers have been typed in the Centre D'Etude du Polymorphisme Humain
collection of three generation families. These families are employed in
developing a genetic map of the human genome. In addition, we have begun
to establish a collection of highly informative markers that can be typed
by the polymerase chain reaction. These markers are microsatellites,
regions of the genome that contain repetitive sequences 2-5 base pairs in
length, that are highly polymorphic. To date, we have synthesized primers
for 65 microsatellite loci and have tested them to confirm their
polymorphism. These markers are extremely valuable for linkage mapping
projects, as well as analysis of allele sharing amongst siblings. One
particular marker that we are extensively studying is in the tumor
necrosis factor (TNF) gene cluster. The TNF genes are located within the
HLA locus and play a crucial role in immune function. We have also
established a microsatellite repeat in the CD4 gene. Both the CD4 and TNF
polymorphisms are being typed in groups of patients exposed to HIV to look
for associations with disease in these individuals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GENETIC ANALYSIS OF MULTIDRUG RESISTANCE GENES
-
批准号:2463679
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
GENETIC ANALYSIS OF MULTIDRUG RESISTANCE GENES
-
批准号:3838501
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
MOLECULAR ANALYSIS OF THE NEVOID BASAL CELL CARCINOMA GENE
-
批准号:6160940
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
ROLE OF CHEMOKINES AND CHEMOKINE RECEPTORS IN AIDS
-
批准号:2463669
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
GENETIC ANALYSIS OF MULTIDRUG RESISTANCE GENES
-
批准号:3774914
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
GENETIC ANALYSIS OF MULTIDRUG RESISTANCE GENES
-
批准号:3752752
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
ROLE OF CHEMOKINES AND CHEMOKINE RECEPTORS IN AIDS
-
批准号:6160946
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
MOLECULAR ANALYSIS OF THE CYSTIC FIBROSIS GENE
-
批准号:5201530
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
MOLECULAR ANALYSIS OF THE NEVOID BASAL CELL CARCINOMA GENE
-
批准号:6100840
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
ABC TRANSPORTERS IN HUMAN DISEASE AND DRUG RESISTANCE
-
批准号:6100857
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
MUTATIONAL ANALYSIS OF THE CYSTIC FIBROSIS GENE
-
批准号:3774874
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
GENETIC ANALYSIS OF HIV RESTRICTION AND TUMOR SUPPRESSOR GENES
-
批准号:5201540
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
GENETIC ANALYSIS OF HIV RESTRICTION AND TUMOR SUPPRESSOR GENES
-
批准号:3752726
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
MUTATIONAL ANALYSIS OF THE CYSTIC FIBROSIS GENE
-
批准号:3838438
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
GENETIC ANALYSIS OF HIV RESTRICTION AND TUMOR SUPPRESSOR GENES
-
批准号:3774888
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
GENETIC ANALYSIS OF MULTIDRUG RESISTANCE GENES
-
批准号:5201558
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
MUTATIONAL ANALYSIS OF THE CYSTIC FIBROSIS GENE
-
批准号:3752709
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
ABC TRANSPORTERS IN HUMAN DISEASE AND DRUG RESISTANCE
-
批准号:6160957
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
MOLECULAR ANALYSIS OF THE NEVOID BASAL CELL CARCINOMA GENE
-
批准号:2463662
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:M DEAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
自供能传感阵列同步量化游离DNA与PSA实现前列腺癌的诊断和预后判断
-
批准号:JCZRLH202601177
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
二氢杨梅素通过线粒体代谢重编程抑制DNA同源重组修复逆转口腔癌细胞放疗抵抗的机制研究
-
批准号:2026JJ80500
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:阳帆
-
依托单位:
乳酸通过ESM1-Akt-MDM2-p53通路调控卵巢癌DNA损伤和抗肿瘤免疫应答的分子机制研究
-
批准号:2026JJ81975
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖娇
-
依托单位:
淫羊藿苷通过TET2介导DNA去甲基化调控Hippo-YAP/TAZ通路逆转绝经后骨质疏松症成血管-成骨耦联失衡的机制研究
-
批准号:2026JJ82371
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王哲享
-
依托单位:
CDC45通过调控DNA复制应激促进肝癌发生发展的机制
-
批准号:2026JJ82714
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:赵志坚
-
依托单位:
PCV2茎环结构DNA激活cGAS-STING通路诱导的天然免疫应答的作用研究
-
批准号:2026JJ50413
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王东亮
-
依托单位:
机械力响应型DNA探针用于肿瘤微环境细胞力学可视化与药物筛选研究
-
批准号:2026JJ60135
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:杨思慧
-
依托单位:
孕期多环芳烃暴露与DNA甲基化改变对子代神经发育影响的出生队列研究
-
批准号:2026JJ81844
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吕玲双
-
依托单位:
Compound 3K抑制NBS1乳酸化修饰增强DNA损伤克服胃癌化疗耐药的作用及机制研究
-
批准号:2026JJ82336
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:綦湘毅
-
依托单位:
WSTF/SNF2H 介导的 DNA 损伤在 DPSCs 衰老中的机制研究
-
批准号:ZCLQN26H1401
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:虞其豪
-
依托单位: